Instaderm
Inject. Form. Heal
Vision
To revolutionize regenerative wound care through intelligent biomimetic scaffolds enabling faster, safer, and accessible healing for millions worldwide.
Problem
Chronic and severe wounds heal poorly due to a lack of functional ECM support. Existing dressings are passive, expensive, and ineffective, affecting millions of burn, diabetic, and trauma patients worldwide.
Solution
InstaDerm™ forms a porous ECM-mimetic scaffold directly at the wound site, promoting hemostasis, antibacterial protection, cell proliferation, and accelerated tissue regeneration without toxic crosslinkers.
Potential
Targets the rapidly growing global advanced wound care market projected to exceed multi-billion-dollar valuation, with strong commercialization potential across chronic wounds, burns, regenerative medicine, and biomaterial therapeutics.
Target Beneficiaries
Hospitals, wound-care clinics, surgeons, diabetic and burn patients, regenerative medicine companies, healthcare providers, and global biomedical industries seeking advanced, scalable, and cost-effective wound healing technologies.
Current Users
Successfully validated in preclinical in-vitro and pilot in-vivo wound healing studies, with technology transferred to industry partner Alicorn India Pvt. Ltd. for translational development and commercialization.
